Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 37% ± 11% | |
oligodendrocyte precursor cell | 10 studies | 31% ± 14% | |
astrocyte | 10 studies | 27% ± 9% | |
oligodendrocyte | 10 studies | 31% ± 11% | |
glutamatergic neuron | 8 studies | 37% ± 21% | |
endothelial cell | 6 studies | 24% ± 9% | |
GABAergic neuron | 6 studies | 35% ± 22% | |
club cell | 5 studies | 28% ± 10% | |
type I pneumocyte | 5 studies | 22% ± 3% | |
Mueller cell | 5 studies | 39% ± 9% | |
B cell | 5 studies | 17% ± 2% | |
epithelial cell | 4 studies | 30% ± 15% | |
retinal pigment epithelial cell | 4 studies | 29% ± 13% | |
interneuron | 4 studies | 34% ± 23% | |
microglial cell | 3 studies | 24% ± 3% | |
retinal rod cell | 3 studies | 18% ± 1% | |
memory B cell | 3 studies | 16% ± 1% | |
neuron | 3 studies | 34% ± 15% | |
hepatocyte | 3 studies | 33% ± 19% | |
mast cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3491.71 | 245 / 245 | 100% | 153.22 | 502 / 502 |
thymus | 100% | 4943.80 | 653 / 653 | 100% | 94.43 | 603 / 605 |
brain | 100% | 2213.60 | 2637 / 2642 | 100% | 45.12 | 704 / 705 |
kidney | 100% | 2298.25 | 89 / 89 | 95% | 36.59 | 859 / 901 |
liver | 100% | 2764.04 | 226 / 226 | 94% | 49.49 | 383 / 406 |
breast | 98% | 2378.17 | 452 / 459 | 95% | 78.72 | 1065 / 1118 |
ovary | 100% | 2158.96 | 180 / 180 | 85% | 32.64 | 365 / 430 |
lung | 99% | 1772.77 | 574 / 578 | 78% | 33.49 | 903 / 1155 |
uterus | 100% | 2189.79 | 170 / 170 | 77% | 31.31 | 355 / 459 |
esophagus | 100% | 2714.33 | 1444 / 1445 | 67% | 25.41 | 123 / 183 |
adrenal gland | 89% | 1040.08 | 229 / 258 | 75% | 22.54 | 173 / 230 |
skin | 74% | 2611.26 | 1342 / 1809 | 83% | 38.20 | 390 / 472 |
pancreas | 100% | 4095.56 | 328 / 328 | 42% | 8.25 | 74 / 178 |
bladder | 100% | 1674.86 | 21 / 21 | 37% | 11.80 | 185 / 504 |
stomach | 99% | 1686.95 | 357 / 359 | 21% | 6.71 | 60 / 286 |
intestine | 89% | 1317.07 | 855 / 966 | 15% | 3.88 | 79 / 527 |
spleen | 100% | 1812.95 | 241 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 90.68 | 79 / 80 |
adipose | 99% | 1202.10 | 1188 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 37.34 | 43 / 45 |
peripheral blood | 91% | 1461.66 | 846 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 806.07 | 784 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 847.32 | 1208 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 38.08 | 24 / 29 |
muscle | 3% | 15.63 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003677 | Molecular function | DNA binding |
GO_0050291 | Molecular function | sphingosine N-acyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CERS4 |
Protein name | Ceramide synthase 4 Ceramide synthase 4 (CerS4) (EC 2.3.1.-) (LAG1 longevity assurance homolog 4) (Sphingosine N-acyltransferase CERS4) (EC 2.3.1.24) |
Synonyms | LASS4 |
Description | FUNCTION: Ceramide synthase that catalyzes formation of ceramide from sphinganine and acyl-CoA substrates, with high selectivity toward long and very-long chains (C18:0-C22:0) as acyl donor. . |
Accessions | ENST00000561008.5 H0YMY6 H0YKR4 H0YNR6 ENST00000251363.10 H0YKS3 ENST00000558268.5 H0YN04 ENST00000561053.5 ENST00000558331.5 ENST00000558877.1 H0YLY3 ENST00000560412.1 H0YKC9 ENST00000559336.5 Q9HA82 ENST00000559450.5 |